Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Third Avenue Value Fund Matthew Fine | “Far from the U.K., the Fund has owned shares of Paltac Ltd., Japan's largest distributor of health and beauty products, daily necessities, and over-the-counter pharmaceuticals, since the second quarter of 2024. During the Fund's ownership period, both the operating performance of the business and the total return of the shares have performed well and largely in keeping with our expectations. The company is one of two dominant players in its industry, which entails gathering products from thousands of manufacturers and distributing them to thousands of retail points of sale. The industry is relatively slow-growing and competitive strength derives from a nationwide network of well-located modern distribution facilities, extremely efficient operations and sophisticated technology that enables value-added services to customers. Furthermore, the evolving pressures being exerted upon Japanese management teams and corporate boards to improve capital allocation decision-making, reduce cross-shareholdings and simplify corporate structures continues to gain momentum. In May of 2026, Paltac's parent company Medipal did indeed launch an all-cash tender offer for the 47.6% of Paltac shares it did not already own. The offer price of JPY 6,650 per share amounts to a reasonable premium of approximately 40%, compared to the pre-announcement price, and the tender offer is scheduled to close in early July. It is likely that this tender offer will mark the end of a successful investment in Paltac for the Fund.” | BULL | Q2 2026 Jul 17, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
